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Brain abscess can be life-threatening and manifest various neurological findings, although
the mortality rate has decreased recently. We investigated the risk factors for unfavorable
outcomes of patients with brain abscess.
Methods
A retrospective cohort study examined patients with brain abscess seen from May 2005 to
December 2018 in a tertiary care hospital in Seoul, South Korea. We reviewed the medical
records for clinical findings, therapeutic modalities, and prognostic factors of brain abscess.
Unfavorable clinical outcomes were defined as death, moderate to severe disability with
neurological deficits, or vegetative state at 1 year or at the time of discharge from outpatient
follow-up.
Results
The study enrolled 135 patients: 65.2% were males; the mean age was 56 years. 35.6%
had unfavorable outcomes. In multivariate analysis, higher Sequential Organ Failure
Assessment (SOFA) (p < 0.001), pre-existing hemiplegia (p = 0.049), and higher Charlson
comorbidity index (CCI) (p = 0.028) were independently associated with unfavorable
outcomes.
Conclusions
Higher SOFA, pre-existing hemiplegia and higher Charlson comorbidity index were signifi-
cant risk factors for unfavorable clinical outcomes in patients with brain abscess.
Introduction
A brain abscess is a severe purulent infection of the brain, and its worldwide prevalence is 0.4–
0.9 persons per 1,000 population [1–3]. Abscesses result from cerebritis, where a capsule forms
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around the area of inflammation and has a pus-filled center composed of necrotic brain tissue
and bacteria. Edema is also increased in the surrounding white matter [3–5].
In the past, brain abscess was invariably fatal. The mortality rate of brain abscess has
decreased from 40% to 10% over the past 50 years with the introduction of computed tomogra-
phy (CT), the development of neurosurgical techniques, and the use of broad-spectrum antibi-
otics [4, 6–8].
Brain abscess can be life-threatening and have severe neurological sequelae, such as motor
weakness, aphasia, and epilepsy [9–11]. Thus, it is important to identify predictors of clinical
outcomes of brain abscess. To our knowledge, however, few studies have done this. Therefore,
we investigated the risk factors for unfavorable clinical outcomes of patients with brain
abscess.
Methods
Study population and design
A retrospective cohort study examined patients with brain abscess from May 2005 to Decem-
ber 2018 in a 2,400-bed, tertiary care hospital in Seoul, South Korea. The patients enrolled met
the following criteria: (1) aged 18 years or over; (2) symptoms including fever, headache and
altered mental status, which are deemed the classical clinical findings of brain abscess [4, 12–
15]; (3) brain CT or magnetic resonance imaging findings showing intracranial brain abscess;
and (4) evidence of brain abscess seen on aspiration or in microbiological samples. Patients
with fungal, mycobacterial, or parasitic infection, and those with other forms of intracranial
abscess, such as an epidural abscess or subdural empyema, were excluded [9]. Demographic
data, and data on neurological status on admission, clinical presentation, risk factors for an
unfavorable outcome, microbiological profiles, neuroimaging findings, treatment modalities,
and clinical outcomes were collected from the electronic medical records. Patients were
divided into favorable and unfavorable outcome groups, at 1 year or at the time of discharge
from out-patient follow-up if earlier. The study was approved by the Institutional Review
Board (IRB) of Yonsei University Health System Clinical Trial Center (4-2020-0160). Because
the study was retrospective and the data were anonymized, the IRB waived the requirement
for consent.
Definitions
Unfavorable clinical outcomes were defined as death, moderate-to-severe disability with
neurological deficits, or vegetative state at 1 year or at the time of discharge from outpatient
follow-up. The outcome was assessed using the Glasgow Outcome Scale, a validated global
scale used to measure the functional outcome following a brain injury, including brain
abscess (Table 1) [16]. The neurological deficits included partial or complete paralysis, par-
tial or complete loss of sensation, seizures, poor cognitive function, or visual defects and dys-
phasia [17–19]. The Charlson comorbidity index (CCI) [20–22] and Sequential Organ
Failure Assessment (SOFA) scores were calculated. The SOFA score comprises six organ sys-
tem function domains (respiratory, cardiovascular, renal, neurological, hepatic, and hemato-
logical) [23–25].
Laboratory tests
Tissue samples were obtained from inflammatory lesions of the frontal, sphenoid, and ethmoid
sinuses. The microorganisms were identified using the ATB 32 GN System (bioMérieux,
Marcy l’Étoile, France) and MALDI Biotyper (Bruker Daltonics, Bremen, Germany).
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Statistical analysis
Independent t-tests were used to analyze continuous variables, and chi-square or Fisher’s exact
tests were used for analyzing categorical variables. A multivariate binary logistic regression
analysis that included significant predictors in the univariate analysis (p< 0.05) was conducted
to identify independent predictors of an unfavorable outcome. The Hosmer–Lemeshow test
was used to determine goodness of fit for logistic regression models. Variables correlated line-
arly with other variables were excluded from the multivariate analysis. A p-value < 0.05 in the
multivariate analysis was considered indicative of statistical significance. The analyses were
performed using SPSS (ver. 25.0; IBM, Armonk, NY, USA).
Results
Baseline characteristics
The study initially investigated 180 patients, of whom 45 were excluded: 31 with epidural abscesses
and 14 with subdural empyema. Finally, 135 patients were eligible for the analysis. Of these, 15 had
brain abscesses in multiple lobes. There were 88 males (65.2%) and 47 females (34.8%). Their mean
age was 56 years. Common clinical findings were focal neurological deficit (51.9%), headache
(45.9%), and fever (29.6%). The most common focal neurological deficits were hemiparesis and dys-
arthria. The most common comorbidities were diabetes mellitus (17.8%) and solid tumor with or
without metastasis (15.6%). Radiologically, 120 (88.9%) had a single lobe abscess and 15 (11.1%) had
abscesses in multiple lobes. The underlying source of the brain abscess was identified in 46 patients
(34.1%): 17 patients (12.6%) had hematogenous spread, 12 (8.9%) had sinusitis, and 9 (6.7%) had a
dental infection. Table 2 shows the patients’ demographic and clinical characteristics.
Surgery was performed in 109 patients (80.7%), of whom 74 underwent drainage, and 35
received open surgery. All patients were treated with systemic antibiotics and 26 patients were
treated only with antibiotics (19.3%) (Table 2). Of these 26 patients, seven did not undergo sur-
gical treatment because they had multiple brain abscesses, in six cases, surgery was not per-
formed because the abscess was smaller than 1 cm, four patients had no surgery due to a
critical medical condition, seven patients had abscesses that were difficult to access surgically,
and two patients with a high risk of bleeding did not undergo surgery.
Microbiological characteristics
Causative pathogens were identified in 44 culture-positive brain abscess patients (32.6%).
Gram-positive bacteria, particularly Streptococcus species, were the most frequently detected
pathogens (Table 3).
Risk factors for unfavorable outcomes among patients with brain abscess
The outcomes were unfavorable in 48 patients (35.6%) (Table 1): 30 patients had a moderate-
to-severe disability, four were in neurovegetative states, and 14 had died by 1 year. In
Table 1. The Glasgow outcome scales of the patients in this study.
Score Clinical Meaning Outcome No. (%)
1 Death unfavorable 14 (10.4)
2 Neurovegetative state; patient unresponsive and speechless for weeks or months unfavorable 4 (3.0)
3 Severe disability; patients dependent for daily support unfavorable 26 (19.2)
4 Moderate disability; patients independent in daily life unfavorable 4 (3.0)
5 Good recovery; resumption of normal life with minor neurological and psychological deficits favorable 87 (64.4)
https://doi.org/10.1371/journal.pone.0257541.t001
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Table 2. Baseline characteristics of the patients with brain abscess.
Variables Total Favorable outcome Unfavorable outcome p-value
(n = 135) (n = 87) (n = 48)
Male (%) 88(65.2) 53(60.9) 35(72.9) 0.161
Age (year, mean±SD) 56±14 53.9±13.1 60.7±14.9 0.015
Presenting symptoms (%)
headache 62(45.9) 54(62.1) 8(16.7) < 0.001
fever (� 37.8˚C) 40(29.6) 29(33.3) 11(22.9) 0.205
seizure 26(19.3) 14(16.1) 12(25.0) 0.209
altered mental status 38(28.1) 15(17.2) 23(47.9) < 0.001
Focal neurologic deficit (%) 70(51.9) 42(48.3) 28(58.3) 0.263
Concomitant meningitis (%) 14(10.4) 8(9.2) 6(12.5) 0.547
Cerebral hemorrhage (%) 8(5.9) 3(3.4) 5(10.4) 0.101
Source of infection (%)
sinusitis 12(8.9) 7(8.0) 5(10.4) 0.643
dental infection 9(6.7) 5(5.7) 4(8.3) 0.564
eye infection 2(1.5) 2(2.3) 0(0) 0.290
otitis 1(0.7) 0(0) 1(2.1) 0.177
head injury 5(3.7) 2(2.3) 3(6.3) 0.245
hematogenous 17(12.6) 9(10.3) 8(16.7) 0.289
unknown 77(57.0) 55(63.2) 22(45.8) 0.051
Site of brain abscess (%)
single lobe 120(88.9) 76(87.4) 44(91.7) 0.446
multiple lobes 15(11.1) 11(12.6) 4(8.3) 0.446
Comorbidity (%)
CHF 6(4.4) 2(2.3) 4(8.3) 0.103
CVA 5(3.7) 2(2.3) 3(6.3) 0.245
peripheral vascular disease 2(1.5) 1(1.2) 1(2.1) 0.673
COPD 1(0.7) 1(1.1) 0(0) 0.456
chronic liver disease 13(9.6) 7(8.0) 6(12.5) 0.401
chronic renal disease 5(3.7) 3(3.4) 2(4.2) 0.832
diabetes mellitus 24(17.8) 12(13.8) 12(25.0) 0.103
non-metastatic solid tumor 19(14.1) 9(10.3) 10(20.8) 0.093
metastatic solid tumor 3(2.2) 1(1.1) 2(4.2) 0.255
hematologic malignancy 2(1.5) 1(1.2) 1(2.1) 0.673
pre-existing hemiplegia 11(8.2) 1(1.1) 10(20.8) < 0.001
CCI (mean±SD 2.44±2.04 1.88±1.7 3.48±2.23 < 0.001
Laboratory data (mean±SD)
WBC (× 103/μL) 10.9±14.6 11.4±17.5 10±5.4 0.721
PLT (× 103/μL) 272.9±120.3 281.9±120.6 255.3±119.2 0.100
BUN (mg/dL) 16.5 ± 14.3 15.1 ±12.2 19.3 ± 17.2 0.087
Cr (mg/dL) 0.9±0.6 0.9±0.7 0.9±0.6 0.633
SOFA (mean±SD) 1.8±2.0 1.2±1.5 3.0±2.2 < 0.001
Treatment modality (%)
open surgery + antibiotics 35(25.9) 25(28.7) 10(20.8) 0.316
drainage + antibiotics 74(54.8) 44(50.6) 30(62.5) 0.183
antibiotics only 26(19.3) 18(20.7) 8(16.7) 0.570
SD, standard deviation; CHF, congestive heart failure; CVA, cerebrovascular attack; COPD, chronic obstructive pulmonary disease; CCI, Charlson comorbidity index;
SOFA, Sequential Organ Failure Assessment; WBC, white blood cells; PLT, platelets; BUN, blood urea nitrogen; Cr, creatinine.
https://doi.org/10.1371/journal.pone.0257541.t002
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univariate analyses, age (p = 0.018), headache (p = 0.001), altered mental status (p< 0.001),
pre-existing hemiplegia (p = 0.004), higher SOFA (p< 0.001), and higher CCI (p< 0.001)
were significantly associated with unfavorable outcomes. In the multivariate analysis, higher
SOFA [p< 0.001, odds ratio (OR) 1.523, 95% confidence interval (CI) 1.206–1.925], pre-exist-
ing hemiplegia (p = 0.049, OR 7.652, 95% CI 1.850–68.919), and higher CCI (p = 0.028, OR
1.279, 95% CI 1.027–1.594) were independent risk factors for unfavorable clinical outcomes in
patients with brain abscess (Table 4).
Discussion
We found that independent risk factors for unfavorable clinical outcomes in patients with
brain abscess were higher SOFA, pre-existing hemiplegia, and higher CCI. Previous studies
have reported some prognostic factors for brain abscess. Zhang et al. reported that female gen-
der was associated with a poor outcome, while Larsen et al. reported that a low Glasgow coma
scale score on admission and comorbidities were related to a poor outcome [2, 26].
Table 3. Bacteria isolated from patients with culture-positive brain abscesses.
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Table 4. Uni- and multivariate analysis of risk factors for unfavorable clinical outcomes in patients with brain abscess.
Variables Univariate Multivariate
OR 95% CI p-value OR 95% CI p-value
Age (per 1-year increase) 1.034 1.006–1.063 0.018 1.003 0.960–1.048 0.905
Headache 0.525 0.999–1.002 0.001 1.000 0.998–1.001 0.648
Altered mental status 4.416 1.997–9.767 <0.001 2.384 0.734–7.739 0.121
Pre-existing hemiplegia 22.368 2.764–181.011 0.004 7.652 1.850–68.919 0.049
CCI (per 1 increase) 1.652 1.299–2.102 <0.001 1.279 1.027–1.594 0.028
SOFA (per 1 increase) 1.578 1.253–1.987 <0.001 1.523 1.206–1.925 <0.001
OR, odds ratio; CI, confidence interval; CCI, Charlson comorbidity index; SOFA, Sequential Organ Failure Assessment.
https://doi.org/10.1371/journal.pone.0257541.t004
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In this study, a higher SOFA was an independent risk factor for an unfavorable outcome.
The SOFA is used to assess organ dysfunction and failure. Several studies have addressed the
relationship between unfavorable outcomes of central nervous system (CNS) infection and the
SOFA score [27–29]. An early change in SOFA is a useful early prognostic marker for sepsis
and mortality. Nakashima et al. found that a high SOFA score was associated with mortality in
patients with critical illness, including CNS infection [30, 31]. In a meta-analysis of 25 studies,
De Grooth et al. revealed a strong association between the SOFA and unfavorable outcomes
[25, 32, 33]. Ferreira et al. showed that serial evaluation of the SOFA during the first 48 hours
could predict the outcome of critically ill patients [34]. The SOFA is a good prognostic mea-
sure in patients with severe illness, including brain abscess.
Pre-existing hemiplegia was also an independent risk factor for an unfavorable outcome.
Patients with hemiplegia as a result of traumatic accidents, strokes, or brain tumors prior to
brain abscess have impaired mobility. McLean et al. reported that less mobile patients had low
lean mass, reduced physical strength, and an elevated mortality rate [35–37]. If damaged brain
tissue is exposed to an infectious agent, the damage is exacerbated, thus increasing the severity
of neurological deficits [38–40]. It is not clear why patients with impaired mobility are more
susceptible to neurological deficits after brain abscess. However, it is likely that their low sta-
mina and damaged brain tissue increase the probability of sequelae after treatment for brain
abscess.
A higher CCI was an independent risk factor for an unfavorable outcome in this study. The
CCI is a widely validated simple measure of the prognosis in numerous medical conditions,
with significant relationships between the CCI and prognosis in multiple diseases [41–44]. A
recent large study reported that the CCI predicted mortality in patients with brain abscess in
Denmark from 1982 through 2016 [45].
This study had several limitations inherent to its retrospective design. As with any observa-
tional study, unmeasured confounders may have influenced the findings. Also, the single-cen-
ter design (one tertiary referral hospital) led to the selection of severe cases only. A multicenter
study including a large patient sample is needed.
In conclusion, in this study, a higher SOFA, pre-existing hemiplegia, and higher CCI were
significantly associated with unfavorable treatment outcomes in patients with brain abscess.
Therefore, we need to consider treatment carefully in patients with brain abscess who have
these predictors.
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